"PLGA-Polymer Encapsulating Tumor Antigen and CpG DNA Administered into the Tumor Microenvironment Elicits a Systemic Antigen-Specific IFN-γ Response and Enhances Survival"
written by Kevin P. Nikitczuk, Rene S. Schloss, Martin L. Yarmush, Edmund C. Lattime,
published by Journal of Cancer Therapy, Vol.4 No.1, 2013
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Cationic polymers for enhancing CpG oligodeoxynucleotides-mediated cancer immunotherapy
2019
[2] Aptamer-mediated polymeric vehicles for enhanced cell-targeted drug delivery
Current Drug Targets, 2018
[3] Polymeric Immunonanoparticles Mediated Cancer Therapy: Versatile Nanocarriers for Cell-Specific Cargo Delivery
2018
[4] Soluble PD-1-based vaccine targeting MUC1 VNTR and survivin improves anti-tumor effect
Immunology Letters, 2018
[5] Combinatory therapy adopting nanoparticle-based cancer vaccination with immune checkpoint blockade for treatment of post-surgical tumor recurrences
Journal of Controlled Release, 2018
[6] Polymer nanoparticles as adjuvants in cancer immunotherapy
Nano Research, 2018
[7] CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies
International journal of nanomedicine, 2017
[8] Polymeric Immunonanoparticles Mediated Cancer Therapy: A Versatile Nanocarriers for Cell Specific Cargo Delivery
2017
[9] Modulation of Dendritic Cells by Nanotechnology-Based Immunotherapeutic Strategies
Journal of Biomedical Nanotechnology, 2016
[10] Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2016
[11] DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy
Pharmacology & Therapeutics, 2016
[12] The addition of recombinant vaccinia HER2/neu to oncolytic vaccinia-GMCSF given into the tumor microenvironment overcomes MDSC-mediated immune escape …
Cancer Gene Therapy, 2015
[13] Formulation, characterization and validation of CpG functionalized PLGA bacteriomimetic nanoparticles for breast cancer immunotherapy
2015
[14] The addition of recombinant vaccinia HER2/neu to oncolytic vaccinia-GMCSF given into the tumor microenvironment overcomes MDSC-mediated immune escape and systemic anergy
Cancer gene therapy, 2015
[15] Enhancement of anti-tumor effect of particulate vaccine delivery system by'bacteriomimetic'CpG functionalization of poly-lactic-co-glycolic acid nanoparticles
Nanomedicine, 2015
[16] Enhancement of anti-tumor effect of particulate vaccine delivery system by 'bacteriomimetic'CpG functionalization of poly-lactic-co-glycolic acid nanoparticles
2015
[17] 靶向免疫系统的递药系统研究进展
中国药科大学学报, 2015
[18] The addition of recombinant vaccinia HER2/neu to oncolytic vaccinia-GMCSF given into the tumor microenvironment overcomes MDSC-mediated immune escape …
Cancer Gene Therapy, 2015
[19] Recent progress concerning CpG DNA and its use as a vaccine adjuvant
Expert review of vaccines, 2014
[20] Targeting myeloid cells using nanoparticles to improve cancer immunotherapy
Advanced drug delivery reviews, Elsevier, 2014